Significant Agreements (Details) - USD ($) $ in Millions |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 17, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Immunovia AB [Member] | |||
| Significant Agreements [Line Items] | |||
| License revenue | $ 0.6 | ||
| License Agreement [Member] | |||
| Significant Agreements [Line Items] | |||
| Non-refundable upfront license fee | $ 0.3 | ||
| Payments for study-related services | $ 0.3 |
| X | ||||||||||
- Definition The amount of non-refundable upfront license fee. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for professional and contracted services. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|